Posted on 12/12/19
Stemline Therapeutics: Post-ASH Update For This Leader In The CD123 Space
SummaryShares have lost a third of their value since my August recommendation.I provide a recap of the bullish thesis and recent events.Opportunity for ELZONRIS in CMML . . .
Posted on 12/11/19
Merck: Adding To The Pipeline
SummaryMerck is acquiring ArQule at quite a hefty premium, what is a bolt-on deal for the company nonetheless.The company continues to thrive on Keytruda sales growth, . . .
Posted on 12/11/19
Intercept Pharmaceuticals: Blockbuster Therapy Unveils An Upside Catalyst
SummaryIntercept is likely to introduce the first successful NASH therapy early next year.The barriers to entry and lack of competition should consolidate market access.While the higher . . .
Posted on 12/11/19
Here's Why Intercept Pharmaceuticals Stock Rose 48.9% in November
What happenedShares of Intercept Pharmaceuticals (NASDAQ:ICPT), a biopharmaceutical company, were up 48.9% in November, according to data from S&P Global Market Intelligence. An interim analysis of . . .
Posted on 12/11/19
Rocket Pharmaceuticals Proposes Public Offering of Common Stock
NEW YORK--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today announces that . . .
Posted on 12/11/19
Rocket Pharmaceuticals Prices Public Offering of Common Stock
NEW YORK--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today announces the . . .
Posted on 12/10/19
Health System Opens Specialty Center With Same-Day Diagnosis, Testing, And Treatment
ProHEALTH Care, the largest independent, physician-run health system in the nation, officially opened its new ProHEALTH Center for Neck and Back Pain at a special ribbon-cutting . . .
Posted on 12/10/19
LEO Pharma Joins Certara’s PBPK Simcyp Simulator Consortium
PRINCETON, N.J.--(BUSINESS WIRE)--Certara, the global model-informed drug development and decision support leader, today announced that LEO Pharma has licensed its proprietary Simcyp® Population-based Simulator and joined . . .
Posted on 12/10/19
MetLife Named One of America’s Most Responsible Companies
NEW YORK--(BUSINESS WIRE)--MetLife, Inc., today announced that it has been named one of America’s “Most Responsible Companies” by Newsweek magazine. MetLife is the top-ranked insurance company . . .
Posted on 12/10/19
Canepa Healthcare changes Name to Evidity Health Capital
Canepa Healthcare, the late-stage venture capital and growth equity firm focusing on medical technology, unveiled its new name today, Evidity Health Capital.The new brand reflects Evidity's . . .
Posted on 12/10/19
SCYNEXIS Announces Pricing of $35 Million Public Offering
SCYNEXIS, Inc. (NASDAQ: SCYX) today announced the pricing of its previously announced underwritten public offering of 38,888,889 shares of common stock and warrants to purchase up . . .
Posted on 12/10/19
Amneal To Acquire Majority Interest in AvKARE
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) and AvKARE Inc. today announced they have entered into a definitive agreement
Posted on 12/10/19
Current Health Closes $11.5 Million Series A Funding Round
Current Health, which offers the leading FDA-cleared, artificial intelligence (AI)-powered patient management platform, today announced it has closed a $11.5 million (£9 million) Series A funding
Posted on 12/10/19
Immunomedics Closes Public Offering of Common Stock
MORRIS PLAINS, N.J., Dec. 09, 2019 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ: IMMU), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today announced . . .
Posted on 12/10/19
Akers BioSciences Closes Approximately $8 Million Public Offering
Thorofare, New Jersey, Dec. 09, 2019 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER), a developer of rapid health information technologies, today announced the closing of . . .
Posted on 12/10/19
Relmada Therapeutics Closes $115M Public Offering of Common Stock
Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today announced the closing of its . . .
Posted on 12/10/19
SCYNEXIS Announces Launch of Public Offering of Common Stock
SCYNEXIS, Inc. (NASDAQ : SCYX) today announced that it has commenced an underwritten public offering of shares of its common stock and warrants. In addition, SCYNEXIS . . .
Posted on 12/10/19
Quest Diagnostics Prices $800 Million of Senior Notes
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today the pricing of a public offering of $800 million aggregate principal . . .
Posted on 12/9/19
HSS Extends Global Network to Colombia with New Collaboration
HSS, the world's leading academic medical center focused on musculoskeletal health headquartered at Hospital for Special Surgery in New York, today announced a strategic collaboration with . . .
Posted on 12/9/19
Zentalis Pharmaceuticals Raises $85 Million in Oversubscribed Series C
Zentalis Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing clinically differentiated, novel small molecule therapeutics
Posted on 12/9/19
Bristol-Myers Squibb Prescribed For The Newborn Portfolio
Summary Newborn Portfolio update; increase in cash position, as well as a new position added in the portfolio. After a lot of homework and research, Bristol-Myers . . .
Posted on 12/9/19
Bristol Myers Squibb: A Cash-Generating Machine at a Cheap Price
With the market at an all-time high, an investor would be hard-pressed to find a stock trading at an earnings multiple that's less than its growth . . .
Posted on 12/9/19
Better Buy: Pfizer vs. Bristol-Myers Squibb
A lot is changing for two of the biggest drugmakers on the planet. Pfizer (NYSE:PFE) is merging its Upjohn business with Mylan (NASDAQ:MYL). Bristol-Myers Squibb (NYSE:BMY) . . .
Posted on 12/9/19
Antares Pharma Social Media Campaign for XYOSTED Wins MarCom Platinum Award
EWING, N.J., Dec. 06, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“Antares”) (“the Company”) today announced that the Company’s social media campaign for XYOSTED®, . . .
Posted on 12/8/19
IVERIC bio Prices Public Offering of Common Stock
NEW YORK--(BUSINESS WIRE)--IVERIC bio, Inc. (Nasdaq: ISEE) announced the pricing of an underwritten public offering of 6,250,000 shares of its common stock at a price to . . .
New York
